Business Context and Reporting Period
This Form 8-K Current Report covers events occurring on November 6, 2015, for Gevo, Inc., a Delaware corporation. The filing reports the entry into material definitive agreements with Praj Industries Ltd. ("Praj") to establish a strategic partnership focused on the development and commercialization of renewable isobutanol ("Biobutanol").
Key Financial Metrics
This filing is a Current Report regarding a material agreement and does not contain financial statements, revenue figures, profit data, cash flow metrics, debt levels, or liquidity ratios. No financial performance data is provided in this document.
Material Changes and Agreements
On November 6, 2015, Gevo entered into two primary agreements with Praj:
- Joint Development Agreement (JDA):
- Scope: Jointly develop Gevo's technology for use in ethanol plants utilizing specific feedstocks (sugarcane, sugar beet, cassava, rice, cellulosic sugars) and develop engineering packages for greenfield Biobutanol plants and retrofits.
- Roles: Praj holds exclusive rights to supply equipment and process engineering services for covered plants. Gevo retains the right to negotiate commercial licenses and will be the exclusive seller of all Biobutanol produced by plants subject to the JDA.
- Duration: Two years from the effective date, terminable by either party.
- Development License Agreement:
- License Grant: Gevo granted Praj a non-exclusive, royalty-free license to use Gevo's patents and know-how, plus a sublicense to certain Butamax patents, solely for process development and manufacturing at Praj's Matrix plant in Pune, India.
- Restrictions: Praj must use only Gevo's biocatalysts and separation technology. Praj cannot use third parties to produce Biobutanol or sublicense rights without Gevo's consent.
- Intellectual Property: Any improvements made by Praj to the licensed technology must be assigned to Gevo. If assignment is impossible, Gevo receives an exclusive, royalty-free license to such improvements.
- Duration: Two years, renewable for one-year terms by mutual agreement.
Outlook, Risks, and Management Commentary
Strategic Outlook: The agreements aim to optimize parameters for Biobutanol production from diverse feedstocks. Following the completion of development work, Gevo intends to negotiate commercial license agreements with Praj and third parties.
Risks and Contingencies:
- Performance Milestones: Praj must meet certain milestones to maintain its exclusive rights to supply equipment and engineering services.
- Liability: Both parties have agreed to indemnify one another under certain circumstances and have limited their liability under the agreements.
- Termination: Both agreements may be terminated earlier than the two-year term by either party as provided in the contract terms.
Investor Verification Checklist
- Verify the specific milestones Praj must meet to retain exclusive supply rights, as these are not detailed in the summary.
- Review the full text of the Joint Development Agreement (Exhibit 10.1) and Development License Agreement (Exhibit 10.2) for omitted confidential terms.
- Confirm the status of the Patent Cross-License Agreement with Butamax Advanced Biofuels LLC referenced in the filing.
- Monitor future filings for the execution of commercial license agreements following the completion of the development work.
- Check for any subsequent press releases or 8-K filings regarding the termination or renewal of these two-year agreements.